NCT00128596View on ClinicalTrials.gov

Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2005

Conditions
Liver Cancer
Interventions
DRUG

arsenic trioxide

Trial Locations (1)

15232

UPMC Cancer Centers, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT00128596 - Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter